Close Menu

JAMA Drama Continues

The drama at JAMA that began with Jonathan Leo asking the journal to look into Robert Robinson's ties to Forest Laboratories (Robinson published a paper in JAMA saying that Lexapro helped prevent depression in stroke victims) is continuing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.

Feb
18
Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.